Pharmasset, Inc. (VRUS)

S&P 500: 1,056.89
Change: -3.85%

A clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections.

Recs

Avatar Rep07 (98.61) Submitted: 6/17/08 11:44 AM : Start Price: $20.10 VRUS Score: -5.13

Show me why this is worth so much. We're into a bear market so it better be good. Meanwhile ima short this sucka

Featured Broker Partners